triamcinolone

Summary

Summary: A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)

Top Publications

  1. ncbi Conjunctival necrosis following intravitreal injection of triamcinolone acetonide
    Sathish Srinivasan
    Department of Ophthalmology, Arrowe Park Hospital, Wirral, UK
    Cornea 24:1027-8. 2005
  2. pmc Intravitreal triamcinolone reinjection for refractory diabetic macular edema
    Alireza Ramezani
    Ophthalmic Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
    Korean J Ophthalmol 20:156-61. 2006
  3. pmc Bupivacaine and triamcinolone may be toxic to human chondrocytes: a pilot study
    Hasan M Syed
    Department of Orthopaedic Surgery, Loma Linda University Medical Center, 11406 Loma Linda Drive, Suite 218, Loma Linda, CA 92354, USA
    Clin Orthop Relat Res 469:2941-7. 2011
  4. ncbi The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection
    Satoru Hashimoto
    Department of Endoscopy, Niigata University Medical and Dental Hospital, Niigata, Japan
    Gastrointest Endosc 74:1389-93. 2011
  5. ncbi Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
    Gianni Virgili
    Department of Specialised Surgical Sciences, University of Florence, Florence, Italy
    Cochrane Database Syst Rev 12:CD007419. 2012
  6. ncbi Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis
    S Young
    Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
    Clin Experiment Ophthalmol 29:2-6. 2001
  7. ncbi Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis
    Scott Cordray
    Academic Programs at Southern Nazarene University, Tulsa, Okla, USA
    Ear Nose Throat J 84:426-30. 2005
  8. ncbi Triamcinolone decreases bupivacaine toxicity to intervertebral disc cell in vitro
    Ju Hyung Moon
    Department of Neurosurgery, Spine and Spinal Cord Institute, Gangnam Severance Spine Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam Gu, Seoul, South Korea
    Spine J 12:665-73. 2012
  9. ncbi Specific uptake of folate-decorated triamcinolone-encapsulating nanoparticles by retinal pigment epithelium cells enhances and prolongs antiangiogenic activity
    Wai Leung Langston Suen
    Department of Chemical and Biomolecular Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
    J Control Release 167:21-8. 2013
  10. pmc Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema
    Mark C Gillies
    Save Sight and Eye Health Institute, Department of Clinical Ophthalmology, University of Sydney, GPO Box 4337, Sydney NSW 2001, Australia
    Br J Ophthalmol 91:1323-6. 2007

Detail Information

Publications215 found, 100 shown here

  1. ncbi Conjunctival necrosis following intravitreal injection of triamcinolone acetonide
    Sathish Srinivasan
    Department of Ophthalmology, Arrowe Park Hospital, Wirral, UK
    Cornea 24:1027-8. 2005
    To report a case of localized conjunctival necrosis following intravitreal injection of triamcinolone acetonide (TA).
  2. pmc Intravitreal triamcinolone reinjection for refractory diabetic macular edema
    Alireza Ramezani
    Ophthalmic Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
    Korean J Ophthalmol 20:156-61. 2006
    To evaluate the effect of intravitreal triamcinolone acetonide (IVT) reinjection on clinical and optical coherence tomographic features in refractory diabetic macular edema.
  3. pmc Bupivacaine and triamcinolone may be toxic to human chondrocytes: a pilot study
    Hasan M Syed
    Department of Orthopaedic Surgery, Loma Linda University Medical Center, 11406 Loma Linda Drive, Suite 218, Loma Linda, CA 92354, USA
    Clin Orthop Relat Res 469:2941-7. 2011
    ..Given the frequency of use of these agents, it is important to know whether they are in fact toxic...
  4. ncbi The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection
    Satoru Hashimoto
    Department of Endoscopy, Niigata University Medical and Dental Hospital, Niigata, Japan
    Gastrointest Endosc 74:1389-93. 2011
    ....
  5. ncbi Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
    Gianni Virgili
    Department of Specialised Surgical Sciences, University of Florence, Florence, Italy
    Cochrane Database Syst Rev 12:CD007419. 2012
    ..Antiangiogenic therapy with anti-vascular endothelial growth factor (anti-VEGF) modalities has recently been proposed for improving vision in people with DMO...
  6. ncbi Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis
    S Young
    Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
    Clin Experiment Ophthalmol 29:2-6. 2001
    PURPOSE: To report the safety and efficacy of intravitreal triamcinolone in the treatment of inflammatory cystoid macular oedema (CMO) in six patients who were resistant to other forms of therapy...
  7. ncbi Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis
    Scott Cordray
    Academic Programs at Southern Nazarene University, Tulsa, Okla, USA
    Ear Nose Throat J 84:426-30. 2005
    ..placebo-controlled comparison of intranasal hypertonic Dead Sea saline spray and intranasal aqueous triamcinolone spray in 15 patients with seasonal allergic rhinitis. Results were based on a 7-day regimen...
  8. ncbi Triamcinolone decreases bupivacaine toxicity to intervertebral disc cell in vitro
    Ju Hyung Moon
    Department of Neurosurgery, Spine and Spinal Cord Institute, Gangnam Severance Spine Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam Gu, Seoul, South Korea
    Spine J 12:665-73. 2012
    ..Considering the frequent use of these agents in spinal interventions, it is meaningful to know how they affect intervertebral disc cells...
  9. ncbi Specific uptake of folate-decorated triamcinolone-encapsulating nanoparticles by retinal pigment epithelium cells enhances and prolongs antiangiogenic activity
    Wai Leung Langston Suen
    Department of Chemical and Biomolecular Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
    J Control Release 167:21-8. 2013
    ..b>Triamcinolone acetonide (TA) was efficiently encapsulated (>97%) into the folate-decorated nanoparticles and was slowly ..
  10. pmc Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema
    Mark C Gillies
    Save Sight and Eye Health Institute, Department of Clinical Ophthalmology, University of Sydney, GPO Box 4337, Sydney NSW 2001, Australia
    Br J Ophthalmol 91:1323-6. 2007
    The efficacy and safety of repeated injections of intravitreal triamcinolone (IVTA) for diabetic macular oedema is unclear, with results of previous reports conflicting.
  11. ncbi A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema
    Lalit K Verma
    Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
    J Ocul Pharmacol Ther 20:277-84. 2004
    The aim of the present prospective controlled trial was to evaluate the adjuvant role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema (DDME)...
  12. ncbi Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study
    C K M Chan
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong
    Eye (Lond) 19:625-30. 2005
    To assess the intraocular pressure (IOP) and corneal endothelial changes, over a 6-month period, after a single injection of intravitreal triamcinolone (ivTA) in Chinese patients.
  13. pmc De Quervain's disease: efficacy of intra-sheath triamcinolone injection
    Takuya Sawaizumi
    Department of Orthopaedic Surgery, Nippon Medical School, 1 1 5 Sendagi, Bunkyo ku, Tokyo 113 8603, Japan
    Int Orthop 31:265-8. 2007
    The methods and clinical outcomes of intra-sheath triamcinolone injection in the treatment of de Quervain's disease are described. We used 38 hands of 36 patients...
  14. ncbi Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone
    Chi Kong Yeung
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, China
    Jpn J Ophthalmol 48:236-42. 2004
    b>Triamcinolone acetonide (TA) is a corticosteroid that can be used in the treatment of cystoid macular edema (CME) and other ocular inflammatory conditions...
  15. doi Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure
    Kathryn J Martires
    Exp Dermatol 20:280-2. 2011
    ..Concerns regarding malignancy risk resulted in its black box warning in 2006. The purpose of this study is to determine the effects of pimecrolimus on Langerhans cells (LC), mediators of the cutaneous immunity UV-irradiated skin...
  16. ncbi New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars
    Ali Asilian
    Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
    Dermatol Surg 32:907-15. 2006
    ..Keloids and hypertrophic scars are benign growths of dermal collagen that usually cause major physical, psychological, and cosmetic problems...
  17. ncbi Determination of triamcinolone in human plasma by a sensitive HPLC-ESI-MS/MS method: application for a pharmacokinetic study using nasal spray formulation
    Isabela Costa César
    Instituto de Ciências Farmacêuticas, Alameda Coronel Eugênio Jardim 53, 74175 100 Goiânia, GO, Brazil
    J Mass Spectrom 46:320-6. 2011
    ..ionization tandem mass spectrometry (HPLC-ESI-MS/MS) method for the quantitation of triamcinolone in human plasma after nasal spray application was developed and validated...
  18. ncbi The effects of commercially available preservative-free FDA-approved triamcinolone (Triesence®) on retinal cells in culture
    Leandro Cabral Zacharias
    Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, CA 92697, USA
    J Ocul Pharmacol Ther 27:143-50. 2011
    To evaluate the effects of Triesence® (TRI), a new preservative-free triamcinolone approved by the U.S...
  19. ncbi Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind,
    Kim Hørslev-Petersen
    Department of Rheumatology, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark South Jutland Hospital, Institute of Regional Health Services Research, University of Southern Denmark, Odense, Denmark
    Ann Rheum Dis 73:654-61. 2014
    ..protocol (Clinical Trials:NCT00660647) studied whether adalimumab added to methotrexate and intra-articular triamcinolone as first-line treatment in early rheumatoid arthritis (ERA) increased the frequency of low disease activity (..
  20. ncbi Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion
    Soon Il Kwon
    Department of Ophthalmology, Hallym University College of Medicine, Anyang, Korea
    J Ocul Pharmacol Ther 29:5-9. 2013
    ..secondary to branch retinal vein occlusion (BRVO) and to compare the visual outcome and macular thickness with eyes treated with intravitreal injection of triamcinolone acetonide (IVTA) and intravitreal injection of bevacizumab (IVB).
  21. ncbi Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema
    R Forte
    Dipartimento di Scienze Oftalmologiche, Universita Federico II, Naples, Italy
    Eye (Lond) 24:1325-30. 2010
    ..persistent non-ischaemic diffuse diabetic macular oedema (DME) treated with intravitreal bevacizumab (IVB) or with intravitreal injection of triamcinolone combined with macular laser grid (IVTA-MLG) from September 2005 to February 2008.
  22. ncbi Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars
    A Darougheh
    Skin Diseases and Leishmaniasis Research Centre, and Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
    Clin Exp Dermatol 34:219-23. 2009
    ..Keloids and hypertrophic scars are benign growths of dermal collagen that can cause physical and psychological (cosmetic) problems for patients...
  23. ncbi Clean intermittent catheterization with triamcinolone ointment following internal urethrotomy
    Jalil Hosseini
    Division of Reconstructive Urology, Shohada e Tajrish Hospital and Urology and Nephrology Research Center, Shahid Beheshti University MC, Tehran, Iran
    Urol J 5:265-8. 2008
    Our aim was to evaluate clean intermittent catheterization (CIC) results in combination with triamcinolone ointment for lubrication of the catheter after internal urethrotomy.
  24. ncbi Triamcinolone reduces seroma re-accumulation in the extended latissimus dorsi donor site
    Rieka Taghizadeh
    Canniesburn Plastic Surgery Unit, Glasgow, UK
    J Plast Reconstr Aesthet Surg 61:636-42. 2008
    ..We designed a double-blind randomised controlled trial to test the hypothesis that an intracavity injection of the anti-inflammatory corticosteroid triamcinolone would inhibit seroma re-accumulation.
  25. ncbi [Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration]
    R Hahn
    Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Wien, Wahringer Gurtel 18 20, Wien, Osterreich
    Ophthalmologe 104:588-93. 2007
    The aim of this study was to compare intravitreal bevacizumab (IVB) and verteporfin therapy in combination with 4 mg intravitreal triamcinolone (PDT-IVTA) in patients with neovascular age-related macular degeneration (AMD).
  26. ncbi Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study?
    Shalom E Kelman
    J Neuroophthalmol 27:161-3. 2007
  27. ncbi Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids
    Steven P Davison
    sDepartment of Plastic Surgery, Georgetown University Hospital, Washington, DC 20007, USA
    Aesthet Surg J 29:40-6. 2009
    ..Keloids are a common problem with significant recurrence rates despite intralesional steroid treatment and multimodal therapy...
  28. ncbi Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone
    Kazuyuki Hirooka
    Department of Ophthalmology, Kagawa University Faculty of Medicine, Miki, Kagawa, Japan
    Jpn J Ophthalmol 50:235-8. 2006
    To determine the risk factors that induce an elevation of intraocular pressure (IOP) after trans-Tenon retrobulbar injections of triamcinolone acetonide.
  29. ncbi Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study
    David W J Cote
    Division of Otolaryngology, Head and Neck Surgery, University of Alberta, Edmonton, Alberta, Canada
    Laryngoscope 120:1269-73. 2010
    ..To evaluate the impact of steroid-impregnated absorbable nasal dressing on wound healing and surgical outcomes after endoscopic sinus surgery (ESS)...
  30. ncbi Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications
    Ihab Saad Othman
    6 Tahrir Street, Dokki, Giza, Egypt
    Br J Ophthalmol 94:606-10. 2010
    AIM To evaluate the role of intravitreal Triamcinolone (TA) in the early management of Coats disease. METHODS Retrospective, interventional case series. RESULTS 15 consecutive cases with Coats disease were managed with 4 mg/0...
  31. ncbi Management of lichen sclerosus with triamcinolone ointment: effectiveness in reduction of patient symptom scores
    Cherie LeFevre
    Department of Obstetrics, Gynecology, and Women s Health, Saint Louis University, Saint Louis, MO, USA
    J Low Genit Tract Dis 15:205-9. 2011
    To determine whether topical triamcinolone ointment effectively reduces patient's symptoms for the management of lichen sclerosus (LS).
  32. ncbi Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease
    Chris S Bergstrom
    Emory Eye Center, Emory University School of Medicine, Atlanta, Georgia, USA
    Retina 28:S33-7. 2008
    Intravitreal triamcinolone injection effectively reduces subretinal fluid in pediatric patients with exudative retinal detachments in severe Coats disease...
  33. ncbi [Use of triamcinolone and bevacizumab in 25G phaco-vitrectomy surgery for the treatment of cataract and diabetic macular edema]
    S E Hernández-Da Mota
    Unidad de Oftalmologia, Clínica David, Morelia, Mich, Mexico
    Arch Soc Esp Oftalmol 83:293-300. 2008
    To evaluate the safety and efficacy of combined phacoemulsification and triamcinolone-assisted vitrectomy with intravitreal injection of bevacizumab in patients with cataract and diffuse diabetic macular edema.
  34. pmc Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema
    S D M Chen
    Br J Ophthalmol 88:843-4. 2004
  35. ncbi [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema]
    E Khurieva-Sattler
    Klinik fur Augenheilkunde, Universitatsklinikum des Saarlandes, Homburg Saar
    Klin Monbl Augenheilkd 227:496-500. 2010
    Visual outcome and anatomic results in patients with diffuse diabetic macular oedema (DDME) were evaluated after vitrectomy with internal limiting membrane (ILM) peeling versus intravitreal triamcinolone acetonide (TA).
  36. ncbi The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane
    Chi Chun Lai
    Department of Ophthalmology, Chang Gung Memorial Hospital, Linkuo Medical Center, Taoyuan, Taiwan
    Cutan Ocul Toxicol 30:292-7. 2011
    To compare the long-term anatomical and visual outcomes of patients with idiopathic epiretinal membrane (ERM) removed by vitrectomy and membrane peeling with or without the use of intravitreal injection of triamcinolone acetonide (IVTA).
  37. ncbi [Leak of intravitreal triamcinolone to the anterior chamber]
    C Blanco
    Servicio de Oftalmologia, Unidad Retina Vítrea, Complejo Hospitalario Universitario de Albacete, Albacete, Espana
    Arch Soc Esp Oftalmol 82:781-3. 2007
    A 78-year-old man with phakic eyes underwent photodynamic therapy followed by intravitreal injection of triamcinolone. During the injection a white solution was observed in the anterior chamber...
  38. ncbi [Triamcinolone-assisted vitrectomy in the treatment of recurrent retinal detachment due to myopic macular hole]
    J F Le Rouic
    Département de Chirurgie Vitréo Rétinienne, Clinique Sourdille, 8, rue Camille, Flammarion, 44000 Nantes
    J Fr Ophtalmol 29:829-34. 2006
    To report the use of triamcinolone-assisted vitrectomy to assess the cause of vitrectomy failure in the treatment of retinal detachment due to myopic macular hole.
  39. ncbi Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results
    S Sacu
    Department of Ophthalmology, Medical University of Vienna, Vienna, Austria
    Eye (Lond) 23:2223-7. 2009
    To compare 1-year functional and anatomic outcomes of intravitreal bevacizumab (IVB) and photodynamic therapy plus intravitreal triamcinolone (PDT+IVTA) combination in patients with neovascular age-related macular degeneration (AMD).
  40. pmc Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone
    P P Yip
    Department of Ophthalmology, Tuen Mun Hosptial, Tsing Chung Koon Road, Tuen Mun, Hong Kong
    Br J Ophthalmol 93:754-8. 2009
    ..therapy consisting single-session photodynamic therapy (PDT), intravitreal bevacizumab (IVB) and intravitreal triamcinolone (IVTA) for treatment of neovascular age-related macular degeneration (AMD) METHODS: Consecutive patients with ..
  41. ncbi Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion
    Srilaxmi Bearelly
    Albert Eye Research Institute, Duke University Eye Center, Department of Ophthalmology, Durham, NC 27710, USA
    Ann Ophthalmol (Skokie) 38:317-20. 2006
    We retrospectively evaluated the effectiveness of intravitreal triamcinolone in treating 19 eyes with macular edema related to branch retinal vein occlusion (BRVO)...
  42. ncbi Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study
    G Weigert
    Department of Ophthalmology, Medical University of Vienna, Vienna, Austria
    Br J Ophthalmol 92:356-60. 2008
    ..functional and anatomical outcomes of intravitreal bevacizumab (Avastin) and verteporfin (photodynamic) therapy (PDT) combined with intravitreal triamcinolone (IVTA) in patients with neovascular age-related macular degeneration (AMD).
  43. ncbi Papular elastorrhexis in childhood improved by intralesional injections of triamcinolone
    S H Lee
    Department of Dermatology, College of Medicine, Gyeongsang National University, Chinju, Korea
    J Dermatol 28:569-71. 2001
    ..His skin lesions were improved by intralesional injections of triamcinolone but recurred after four months.
  44. ncbi A controlled study of caudal epidural injections of triamcinolone plus procaine for the management of intractable sciatica
    K Bush
    Department of Rheumatology, Royal Free Hospital, London
    Spine (Phila Pa 1976) 16:572-5. 1991
    ..This preliminary study assesses the efficacy of epidural injections of 80 mg triamcinolone acetonide plus 0...
  45. ncbi Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study
    A Ashkenazi
    Department of Neurology, Thomas Jefferson University, 111 South 11th Street, Suite 8130, Philadelphia, PA 19107, USA
    J Neurol Neurosurg Psychiatry 79:415-7. 2008
    To determine whether adding triamcinolone to local anaesthetics increased the efficacy of greater occipital nerve block (GONB) and trigger-point injections (TPIs) for transformed migraine (TM).
  46. ncbi Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy
    Berkant Kaderli
    Department of Ophthalmology, Uludag University School of Medicine, 16059 Gorukle Campus, Bursa, Turkey
    J Neuroophthalmol 27:164-8. 2007
    ..Because intravitreal triamcinolone (IVTA) has shown promise in improving edematous retinal disorders, a pilot trial of this therapy in NAION was ..
  47. doi Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy
    Sohan Singh Hayreh
    J Neuroophthalmol 28:77-8; author reply 78-9. 2008
  48. pmc Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice
    Aaltien Brinks
    Department of General Practice, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
    BMC Musculoskelet Disord 8:95. 2007
    ..The cost effectiveness of the corticosteroid injection therapy will also be assessed. Secondly, the role of co-morbidity in relation to the efficacy of local corticosteroid injections will be investigated...
  49. ncbi Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema
    Michael S Ip
    Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, WI 53792, USA
    Diabetes Care 27:1794-7. 2004
  50. ncbi A prospective randomized controlled trial of injection of dexamethasone versus triamcinolone for idiopathic trigger finger
    David Ring
    Harvard Medical School, Boston, MA, USA
    J Hand Surg Am 33:516-22; discussion 523-4. 2008
    ..was designed to test the null hypothesis that there is no difference in resolution of triggering 3 months after injection with either a soluble (dexamethasone) or insoluble (triamcinolone) corticosteroid for idiopathic trigger finger.
  51. ncbi Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections
    Julian S Conejo-Mir
    Department of Dermatology, Hospital Universitario Virgen del Rocio, Seville, Spain
    Dermatol Surg 32:1079-81; discussion 1082. 2006
  52. ncbi Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study
    Alexandros A Rouvas
    2nd Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Retina 29:536-44. 2009
    To compare 1) intravitreal ranibizumab, 2) intravitreal ranibizumab plus photodynamic therapy (PDT), and 3) intravitreal triamcinolone plus PDT in retinal angiomatous proliferation.
  53. ncbi The effect of intravitreal triamcinolone on intraocular pressure
    Mark Kramar
    Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Curr Med Res Opin 23:1253-8. 2007
    To evaluate the effect of triamcinolone acetonide (ITA) on intraocular pressure (IOP) following intravitreal injection, and, in those patients who experience post-injection elevation of IOP, to determine the time course, effect of ..
  54. ncbi Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II
    Michael S Eichenhorn
    Henry Ford Hospital, Detroit, MI, USA
    Chest 124:57-62. 2003
    ..One of the potential adverse effects of their use is the development of adrenal suppression. Our study aimed to determine the effects of ICS on adrenal function over 3 years of use in patients with COPD...
  55. ncbi Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia
    Y H Kim
    Department of Anatomy and Neurobiology, College of Medicine, Gyeongsang National University, Chilam dong 92, Jinju, Gyungnam 660 751, South Korea
    Neurobiol Dis 26:569-76. 2007
    We examined the effect of triamcinolone acetonide (TA), a corticosteroid, on the relationship between vascular pathophysiology and vascular endothelial growth factor (VEGF) activation in the retina of a rat model of oxygen-induced ..
  56. pmc Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation
    T R Krieglstein
    Department of Ophthalmology, Ludwig Maximilians University of Munich, Mathildenstr 8, 80336 Munich, Germany
    Br J Ophthalmol 90:1357-60. 2006
    ..The only two therapeutic modalities being discussed are surgical lysis of the feeding arteriole and draining venule, and the use of photodynamic therapy combined with intravitreal triamcinolone injection.
  57. ncbi [Branch retinal vein occlusion treated by intravitreal triamcinolone]
    A Salinas-Alaman
    Departamento de Oftalmologia, Clinica Universitaria de Navarra, Universidad de Navarra
    Arch Soc Esp Oftalmol 80:463-5. 2005
    Five eyes with branch retinal vein occlusion (BRVO) were treated with intravitreal injection of 4 mg of triamcinolone. Four cases showed good visual acuity and macular thickness evolution after one dose...
  58. pmc Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
    Hamid Ahmadieh
    Ophthalmic Research Center, Shaheed Beheshti Medical University, Labbafinejad Medical Center, Tehran, Iran
    BMC Ophthalmol 7:10. 2007
    ..consisting of single-session photodynamic therapy (PDT), intravitreal bevacizumab (IVB) and intravitreal triamcinolone (IVT) as initial pulse therapy followed by repeat intravitreal bevacizumab injections for maintenance ..
  59. ncbi Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema
    S K Gibran
    Eye, Ear, Nose and Throat Centre, Queens Medical Centre, Nottingham, United Kingdom
    Ophthalmology 114:890-4. 2007
    To identify an optical coherence tomography (OCT) pattern predictive of visual outcome in patients with diabetic macular edema (DME) who underwent a single dose of intravitreal triamcinolone.
  60. pmc Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study
    W M Chan
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, 147K Argyle Street, Hong Kong
    Br J Ophthalmol 90:337-41. 2006
    To evaluate the outcomes of combined intravitreal triamcinolone (IVTA) and photodynamic therapy (PDT) with verteporfin in the treatment of subfoveal choroidal neovascularisation (CNV) caused by age related macular degeneration (AMD).
  61. ncbi Linear hypopigmentation after triamcinolone injection: a rare complication of a common procedure
    V Nanda
    Department of Plastic Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
    Aesthetic Plast Surg 30:118-9. 2006
    The development of linear hypopigmentation after intralesional or intraarticular injection of triamcinolone acetonide has been reported in the literature as a very rare side effect...
  62. ncbi Repeated pseudoendophthalmitis after combined photodynamic therapy and intravitreal triamcinolone
    J Marticorena
    Graefes Arch Clin Exp Ophthalmol 245:1403-4. 2007
  63. ncbi Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease
    Mehmet Cakir
    Beyoglu Eye Training and Research Hospital, Istanbul, Turkey
    J AAPOS 13:94-6. 2009
    ..associated with Best disease responded well to a single intravitreal injection of combined bevacizumab and triamcinolone acetonide...
  64. ncbi Loss of bone density with inhaled triamcinolone in Lung Health Study II
    Paul D Scanlon
    Mayo Clinic, Rochester, MN, USA
    Am J Respir Crit Care Med 170:1302-9. 2004
    ..They used inhaled triamcinolone acetonide, 600 mcg, or placebo, twice daily...
  65. ncbi Visualising vitreous through modified trans-scleral illumination by maximising the Tyndall effect
    M Veckeneer
    Rotterdam Eye Hospital, Schiedamsevest 180, Rotterdam, The Netherlands
    Br J Ophthalmol 93:268-70. 2009
    ..It uses a standard lightpipe for scleral indentation and transillumination. Visualisation of the vitreous using low light levels can be achieved by enhancing the Tyndall effect...
  66. pmc Effects of crystalline glucocorticoid triamcinolone acetonide on cultered human supraspinatus tendon cells
    Herbert Tempfer
    Department of Organismic Biology, Division of Zoology and Functional Anatomy, University of Salzburg, Austria
    Acta Orthop 80:357-62. 2009
    ..Subacromial glucocorticoid injections are widely used for treatment of epiphenomenons of chronic impingement syndrome with the possible side effects of tendon rupture and impaired tendon healing...
  67. ncbi A randomized controlled trial of intra-articular triamcinolone and/or physiotherapy in shoulder capsulitis
    I Ryans
    Rheumatology Department, The Ulster Hospital, Dundonald, Belfast, UK
    Rheumatology (Oxford) 44:529-35. 2005
    To assess the effectiveness of intra-articular triamcinolone injection and physiotherapy singly or combined in the treatment of adhesive capsulitis of the shoulder.
  68. ncbi Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect
    Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Curr Med Res Opin 21:705-13. 2005
    ..Pilot studies of intravitreal triamcinolone acetonide monotherapy revealed promising results in patients with CNV due to AMD, but the visual acuity ..
  69. ncbi Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts
    Lisa A Carroll
    Wound Healing and Tissue Engineering Laboratory, Division of Otolaryngology Head and Neck Surgery, Stanford University Medical Center, Stanford, California, USA
    Dermatol Surg 28:704-9. 2002
    b>Triamcinolone acetonide has been shown to decrease both cellular proliferation and collagen production by dermal fibroblasts. An alteration of cytokine levels may mediate these effects.
  70. ncbi Symmetrical hypopigmentation following triamcinolone injection for de Quervain's tenosynovitis
    A V Evans
    Clin Exp Dermatol 27:247-51. 2002
  71. pmc Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir
    Roshan Ramanathan
    Clinical Parasitology Unit and Helminth Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Clin Infect Dis 47:e97-9. 2008
    ..therapy, which included ritonavir, who developed Cushing syndrome with profound complications after epidural triamcinolone injections...
  72. ncbi Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment
    A Ricciardi
    J Eur Acad Dermatol Venereol 20:1000-1. 2006
  73. pmc Optimising corticosteroid injection for lateral epicondylalgia with the addition of physiotherapy: a protocol for a randomised control trial with placebo comparison
    Brooke K Coombes
    The University of Queensland, Division of Physiotherapy, School of Health and Rehabilitation Sciences, St Lucia, QLD, 4072, Australia
    BMC Musculoskelet Disord 10:76. 2009
    ..Surprisingly, these injections have not been rigorously tested against placebo injections. This study primarily addresses both of these issues...
  74. ncbi Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy
    B Maisch
    Department of Internal Medicine Cardiology, Philipps University, Marburg, Germany
    Eur Heart J 23:1503-8. 2002
    To evaluate efficacy and safety of intrapericardial treatment with the crystalloid corticosteroid triamcinolone in autoreactive pericardial effusion.
  75. pmc Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration
    N T Ranson
    Department of Ophthalmology, Indiana University School of Medicine, 702 Rotary Circle, Indianapolis, IN 46202, USA
    Br J Ophthalmol 86:527-9. 2002
    ..Laser treatment may limit scotoma size, but is unpalatable because of early persistent vision loss. Intravitreal triamacinolone injection may be an acceptable alternative therapy in such disparate cases...
  76. ncbi Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina
    Hua Gao
    Department of Ophthalmology, Baylor College of Medicine, Cullen Eye Institute, 6560 Fannin, Suite 2200, Houston, TX 77030, USA
    Vision Res 44:349-56. 2004
    Intravitreal triamcinolone inhibits choroidal neovascularization. To investigate if vascular endothelial growth factor (VEGF) is affected, we examined VEGF expression after intravitreal triamcinolone administration in rat retina...
  77. ncbi A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids
    A M Layton
    Department of Dermatology, General Infirmary, Leeds, U K
    Br J Dermatol 130:498-501. 1994
    ..The data from this double-blind study, in which intralesional triamcinolone or cryosurgery were used as treatment for keloids, demonstrate that by treating early, and in particular ..
  78. ncbi Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone
    Tamara K Fackler
    Duke Eye Center, Albert Eye Research Institute, North Carolina, USA
    Ann Acad Med Singapore 35:701-5. 2006
    To review the outcomes of eyes with neovascular age-related macular degeneration (AMD) treated with photodynamic therapy (PDT) with verteporfin and intravitreal triamcinolone acetonide injection.
  79. ncbi [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling]
    G B Jaissle
    Universitats Augenklinik, Schleichstrasse 12, 72076, Tubingen, Deutschland
    Ophthalmologe 105:575-7. 2008
    Although current in vitro studies show local cytotoxicity of triamcinolone (TA) crystals if they are in direct contact with cells, a toxic effect of epiretinal TA deposits has not been reported yet clinically...
  80. ncbi Early effects of intravitreal triamcinolone on macular edema: mechanistic implication
    Noriko Miyamoto
    INSERM U598 and University René Descartes, Paris, France
    Ophthalmology 113:2048-53. 2006
    To evaluate the early effects of intravitreal triamcinolone acetonide (TA) on cystoid macular edema associated with retinal vein occlusion and diabetic retinopathy.
  81. ncbi Afyap1, encoding a bZip transcriptional factor of Aspergillus fumigatus, contributes to oxidative stress response but is not essential to the virulence of this pathogen in mice immunosuppressed by cyclophosphamide and triamcinolone
    Jianjun Qiao
    Department of Dermatology, Peking University First Hospital, and Research Center for Medical Mycology, Peking University, Beijing, The People s Republic of China
    Med Mycol 46:773-82. 2008
    ..fumigatus strain in a murine model of invasive pulmonary aspergillosis. Taken together, these results demonstrate that Afyap1 is involved in oxidative stress response but is not an essential virulence factor for A. fumigatus...
  82. ncbi Anterior chamber transit of triamcinolone after intravitreal injection
    Jose M Ruiz-Moreno
    Arch Ophthalmol 123:129-30. 2005
  83. ncbi Visualization of the Cloquet canal during triamcinolone-assisted vitrectomy
    Hiroshi Enaida
    Department of Ophthalmology, Kagoshima University School of Medicine, 8 35 1 Sakuragaoka, Kagoshima 890 8520, Japan
    Arch Ophthalmol 122:1564-5. 2004
  84. ncbi Cutaneous sporotrichosis of face: polymorphism and reactivation after intralesional triamcinolone
    Nand Lal Sharma
    Department of Dermatology, Venereology and Leprosy, Indira Gandhi Medical College, Shimla, India
    Indian J Dermatol Venereol Leprol 73:188-90. 2007
    ..The patient had reactivation of infection following an infiltration of the scar with triamcinolone acetonide injection. Various other aspects of these unusual phenomena are also discussed.
  85. doi Astigmatism and periocular hemangioma
    Michael Goggin
    Ophthalmology 115:1854-5; author reply 1855. 2008
  86. ncbi [A comparative clinical study of the treatment of hypertrophic scars with either intralaesional steroid or silicone gel sheeting]
    Ottó Kelemen
    Baranya Megyei Kórház Pécsi Tudományegyetem, Általános Orvostudományi Kar, OEC, Sebészeti Tanszék 7623 Pécs
    Magy Seb 60:297-300. 2007
    ..Prospective randomized clinical trials should be needed to further clarify their role in the treatment protocols...
  87. ncbi Intralesional steroid injection for proliferative parotid hemangiomas
    Lisa M Buckmiller
    Vascular Anomalies Center, University of Arkansas for Medical Sciences, Arkansas, Children s Hospital, Little Rock, AR, USA
    Int J Pediatr Otorhinolaryngol 72:81-7. 2008
    ..To evaluate the efficacy of proliferative phase intralesional steroid injections in the treatment of parotid hemangiomas...
  88. ncbi Combining triamcinolone and lidocaine for soft tissue injections
    Andrew D Schechtman
    Am Fam Physician 77:1372; author reply 1372. 2008
  89. ncbi Rectal strictures in 19 dogs: 1997-2005
    Craig B Webb
    Department of Clinical Sciences, School of Veterinary Medicine, Colorado State University, 300 West Drake Road, Fort Collins, Colorado 80523, USA
    J Am Anim Hosp Assoc 43:332-6. 2007
    ..Sixteen of 19 dogs underwent balloon dilatation therapy, and 14 of these 16 dogs received intralesional triamcinolone injections...
  90. ncbi The inadvertent administration of intralenticular triamcinolone
    S N Rajak
    Eye (Lond) 21:426-7. 2007
  91. ncbi Surgical removal of massive macular hard exudate combined with intravitreal triamcinolone in diabetic maculopathy
    J F T Li Yim
    Eye (Lond) 21:562-4. 2007
  92. ncbi [Pharmacological therapy of keloids in an athymic mouse model]
    J Blazek
    Abteilung für Plastische Chirurgie und Handchirurgie, DRK Kliniken Berlin Westend
    Handchir Mikrochir Plast Chir 40:81-7. 2008
    ..Therefore, a comparative study on the effect of three pharmacological agents was conducted with human keloid implants in an athymic mouse model...
  93. doi Optical coherence tomography
    Atul Kumar
    Ophthalmology 115:417-8; author reply 418. 2008
  94. ncbi [Uveitic cystoid macular edema: intravitreal triamcinolone]
    M Feucht
    Klinik und Poliklinik für Augenheilkunde des Universitätsklinikums Hamburg Eppendorf
    Klin Monbl Augenheilkd 224:62-5. 2007
    Cystoid macular edema (CME) is the most frequent cause of severe loss of visual acuity in uveitis. Among the systemic corticosteroids and immunosuppressive agents, the local use of intravitreal triamcinolone acetate (TA) is evaluated.
  95. ncbi A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures
    James E East
    Wolfson Unit for Endoscopy, St Mark s Hospital, Harrow, Middlesex, United Kingdom
    Clin Gastroenterol Hepatol 5:1065-9. 2007
    ..Intrastricture steroid injection after balloon dilatation has been reported to reduce the need for repeat dilatation in retrospective series, but no randomized data are available...
  96. ncbi Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection
    Avery H Weiss
    Division of Ophthalmology, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    Ophthalmology 115:390-397.e1. 2008
    ..To document refractive status and visual acuity before and after intralesional corticosteroid injection in children with astigmatism induced by periocular capillary hemangioma (PCH)...
  97. ncbi Comparative adrenocortical suppression in dogs with otitis externa following topical otic administration of four different glucocorticoid-containing medications
    C J Reeder
    Animal Dermitology Clinic, Louisville, KY 40299, USA
    Vet Ther 9:111-21. 2008
    ..tended to have larger adrenocortical suppression compared with the other three formulations (betamethasone, triamcinolone, and mometasone), but the difference was not statistically significant...
  98. ncbi Cheilitis granulomatosa associated with Melkersson-Rosenthal syndrome
    Denise Utsch Gonçalves
    Opthalmology, Otorhinolaryngology and Speech Therapy Department, UFMG Medical School, MG, Brazil
    Braz J Otorhinolaryngol 73:132-3. 2007
    ..She referred previous clinical treatments without success. We proposed intralesional injection of triamcinolone at 20 mg every 15 days associated with oral clofazimine at 50 mg/day for three months...
  99. ncbi A case of cystoid macular edema treated by intravitreal triamcinolone in a patient with systemic lupus erythematosis
    Abha Gupta
    Manchester Royal Eye Hospital, Manchester, United Kingdom
    Ann Ophthalmol (Skokie) 38:153-5. 2006
    We describe the use of intravitreal triamcinolone in the treatment of macular edema associated with systematic lupus erythematosus providing short-term resolution of cystoid macular edema and increase in visual acuity...
  100. ncbi Photodynamic therapy and intravitreal triamcinolone for extrafoveal choroidal neovascularization in neovascular age-related macular degeneration
    Jonathan Etter
    Albert Eye Research Institute, Duke University Eye Center, Durham, NC 27710, USA
    Ann Ophthalmol (Skokie) 38:239-41. 2006
    ..to neovascular age-related macular degeneration treated with photodynamic therapy (PDT) and intravitreal triamcinolone. Nine months following PDT and intravitreal triamcinolone, no ophthalmoscopic or angiographic evidence of ..
  101. ncbi Treatment of mild and severe burns with topical, oral, IM, and IV cortisone
    Robert Fand
    Conn Med 72:441. 2008

Research Grants29

  1. Redox Determinants of Severe Asthma
    Serpil C Erzurum; Fiscal Year: 2010
    ..test our hypotheses through three site-specific aims which use the SARP collaborative network and Systemic Triamcinolone in Asthma Characterization (STAC) protocol...
  2. MECHANICAL STIMULATION OF IVD CELLS
    Lori A Setton; Fiscal Year: 2013
    ..bioactivity will be performed as in Aim 1, and also compared against corresponding values for corticosteroid (triamcinolone acetonide) to test for therapeutic potential against the current standard-of-care...
  3. Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT
    Timothy E McAlindon; Fiscal Year: 2013
    ..by ultrasonography), into an adaptive 2-year randomized double-blind clinical trial of intra-articular triamcinolone 40 mg vs. placebo, every 3 months, administered with ultrasound guidance...
  4. Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma
    Sally E Wenzel; Fiscal Year: 2010
    ..These changes will then be re-evaluated following the triamcinolone treatment...
  5. Severe Asthma From Respiratory Infections
    William W Busse; Fiscal Year: 2010
    ..To test this hypothesis, the Systemic Triamcinolone in Asthma Characterization study will be applied to subjects with severe asthma compared to well-controlled ..
  6. MUST Competitive Renewal
    Michael M Altaweel; Fiscal Year: 2013
    ..Two trials would evaluate the efficacy and safety of intravitreal triamcinolone (Triessence) versus standard subtenons triamcinolone, and intravitreal ranibizumab versus intravitreal ..
  7. Redox disturbances and corticosteroid responses in children with severe asthma
    ANNE MENTRO FITZPATRICK; Fiscal Year: 2013
    ..To test this hypothesis, the intramuscular corticosteroid, triamcinolone, will be administered to children with severe asthma from the metropolitan Atlanta area who remain symptomatic ..
  8. Bioequivalence of topical drug products: in vitro - in vivo correlations
    Audra L Stinchcomb; Fiscal Year: 2013
    ..A systematic examination of several key classes of topical drug products will be undertaken including, but not limited to lidocaine, triamcinolone acetonide, tretinoin, acyclovir and metronidazole.
  9. Vascular Remodeling and Effects of Angiogenic Inhibition
    Patricia Parsons Wingerter; Fiscal Year: 2006
    ..other anti-VEGF inhibitors be deduced and quantified by region-based fractal analysis? Effects of the steriod triamcinolone acetonide will be quantified in the NPDR human retina and in another 2D, optically accessible tissue of ..
  10. Vacsular Remodeling and Effects of Angiogenic Inhibition in Diabetic Retinopathy
    Peter Kaiser; Fiscal Year: 2006
    ..other anti-VEGF inhibitors be deduced and quantified by region-based fractal analysis? Effects of the steriod triamcinolone acetonide will be quantified in the NPDR human retina and in another 2D, optically accessible tissue of ..
  11. XANTHOPHYLL-MEDIATED RETINAL DRUG DELIVERY
    Dennis Marcus; Fiscal Year: 2005
    ..lutein and zeaxanthin will be chemically linked to ketorolac, a non-steroidal anti- inflammatory drug, or triamcinolone, a steroid...
  12. CHROMATIN-GLUCOCORTICOID INFLUENCES IN CLEFT PALATE
    ISAAC BEKHOR; Fiscal Year: 1980
    ..Our objectives include studies on the distribution of labeled triamcinolone acetonide in chromatin to look for the various binding sites for the labeled hormone both in active and ..
  13. Endothelial Transmigration Across the RPE Barrier
    Mary Elizabeth Hartnett; Fiscal Year: 2005
    ..Increased knowledge of the mechanisms that cause this destructive phenomenon may lead to future means to prevent CNV in the neurosensory retina, and thus, reduce vision loss in AMD. ..
  14. OCULAR PEMPHIGOID--MECHANISM OF PATHOGENESIS
    A Ahmed; Fiscal Year: 2001
    ..The immediate clinical impact of this research will be the generation and availability of highly specific and sensitive serological laboratory test for the early diagnosis of OCP. ..
  15. CYTOKINE DYSREGULATION, VIRUSES, AND CHILDHOOD ASTHMA
    ROBERT LEMANSKE; Fiscal Year: 2001
    ..The results of these studies will provide information that will be a major step forward in our understanding of the relative influence that genetic and environmental risk factors on the development of childhood asthma. ..
  16. ASTHMA CLINICAL RESEARCH NETWORK
    ROBERT LEMANSKE; Fiscal Year: 2002
    ....
  17. ASTHMA CLINICAL RESEARCH NETWORK (ACRN)
    Richard Martin; Fiscal Year: 2002
    ....
  18. FEMALE SEXUAL AROUSAL: CLITORAL AND VAGINAL PHYSIOLOGY
    Abdulmaged Traish; Fiscal Year: 2003
    ....
  19. ASTHMA CHRONOBIOLOGY: CENTRAL AND LUNG INTERACTIONS
    Richard Martin; Fiscal Year: 2003
    ....
  20. CARE Network - Madison Clinical Center
    ROBERT LEMANSKE; Fiscal Year: 2008
    ..abstract_text> ..
  21. Treatment of Severe Persistent Asthma
    ROBERT LEMANSKE; Fiscal Year: 2007
    ..abstract_text> ..
  22. OCULAR MELANOMA
    Judy Kim; Fiscal Year: 2003
    ..Standardized clinical and data collection procedures will be employed, and standardized forms will be used in all centers. Central training and certification of all study staff will be required. ..
  23. Fibrogenic factors in ocular cicatricial pemphigoid
    A Ahmed; Fiscal Year: 2004
    ..The studies have significant therapeutic potential. The identified molecules or portion of processes that mediate could be blocked or arrested, and this may result in cessation of disease progression and, prevention of blindness. ..
  24. Gene Delivery to the Trabecular Meshwork
    Douglas Rhee; Fiscal Year: 2004
    ..These studies would set the foundation for future evaluations of the function of MIF in the TM and MIF?s potential as a candidate for gene therapy for the treatment of glaucoma. ..
  25. IMMUNE MECHANISMS OF MIDDLE EAR DISEASE
    David Skoner; Fiscal Year: 2006
    ..The primary hypothesis is that cytokine genotype is predictive of illness expression and of OM incidence during a documented RSV infection in young children. ..
  26. Apoptosis in Retinal Detachments
    David Zacks; Fiscal Year: 2006
    ..This will allow us to develop and test new neuroprotective therapies for improving visual outcomes in retinal disease. ..
  27. The Effect of Mycoplasma on Chronic Asthma
    Richard Martin; Fiscal Year: 2008
    ..pneumoniae and asthma will be obtained through this PPG and will ultimately give new knowledge to the understanding of asthma pathophysiology and potential future novel therapies. ..
  28. Innovative Investigations and Therapies for Asthma
    Richard Martin; Fiscal Year: 2007
    ..The ability to predict who will and will not respond to corticosteroids and additive therapy will greatly improve our ability to treat asthma effectively. ..
  29. Micromass Quattro API TSQ For LC-MS/MS Quantitation
    Walter Hubbard; Fiscal Year: 2002
    ..of phospholipids and products of phospholipid metabolism, fatty acid acyl conjugates of hydrocortisone and triamcinolone acetonide (TAA), neuropeptides, endogenous levels of hydrocortisone and cortisone in nasal and bronchoalveolar ..